Home › Hypoglycemia › Texas
Hypoglycemia clinical trials in Texas
7 studies for Hypoglycemia are looking for participants at sites in Texas.
Cities in Texas
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- M3 Wake Research - Dallas, Dallas
- University of Texas Southwestern Medical Center, Dallas
- SMS Clinical Research, LLC - 400 W. Kearney St, Mesquite
- and 3 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 15, 2026 · NCT07340320A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Baylor Scott and White Research Institute, Dallas
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT04786262Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- Texas Diabetes Institute - University Health System, San Antonio
- South Texas Veterans Health Care System, San Antonio
RecruitingEarly phase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 9, 2025 · NCT00992901The Effects of Bariatric Surgeries on Glucose Metabolism
- Texas Diabetes Institute - University Health System, San Antonio
- South Texas Veterans Health Care System, San Antonio
RecruitingEarly phase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 9, 2025 · NCT02823665Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- Texas Diabetes Institute - University Health System, San Antonio
- South Texas Veterans Health Care System, San Antonio
RecruitingEarly phase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 9, 2025 · NCT01803451Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
- Cook Children's Medical Center, Fort Worth
RecruitingPhase 1
Up to age 18 · All sexes · Updated Jul 16, 2024 · NCT02021604From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.